Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Nuclear Medicine

  Free Subscription

Articles published in Nuklearmedizin

Retrieve available abstracts of 57 articles:
HTML format

Single Articles

    October 2022
  1. SCHEER C, Juptner M, Maier T, Lutzen U, et al
    Unusual accumulation of 177Lu-DOTATATE at the injection site of a COVID-19 vaccination.
    Nuklearmedizin. 2022;61:410-413.

  2. SCHENKE SA, Kreissl MC, Grunert M, Hach A, et al
    Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany.
    Nuklearmedizin. 2022;61:376-384.
    PubMed     Abstract available

    August 2022
  3. GUGGENBERGER KV, Vogt ML, Rowe SP, Higuchi T, et al
    Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1830-7767.
    PubMed     Abstract available

  4. FREUDENBERG LS, Freudenberg BJ, Klett R, Herrmann K, et al
    [Nuclear Medicine Physicians: A threatened species?]
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1907-4122.

  5. AGULOGLU N, Aksu A, Akyol M, Katgi N, et al
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1868-4918.
    PubMed     Abstract available

  6. KREBOLD AK, Schaller T, Appenzeller M, Schwaiblmair M, et al
    [18F]FDG PET/CT guided biopsy confirms diagnosis of granulomatosis with polyangiitis.
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1907-4248.

  7. EILSBERGER F, Luster M, Librizzi D, Rodepeter F, et al
    Medullary Thyroid Carcinoma presenting as an Incidentaloma on Gallium-68-PSMA-PET/CT - Systematic Literature Review and Case Report.
    Nuklearmedizin. 2022 Aug 11. doi: 10.1055/a-1896-0106.

  8. KUGLER A, Kuwert T, Ritt P, Grings A, et al
    Influence of CT metal artifact reduction on SPECT/CT quantification of bone scintigraphy - Retrospective study for selected types of metal implants.
    Nuklearmedizin. 2022 Aug 9. doi: 10.1055/a-1883-9281.
    PubMed     Abstract available

  9. ABOUZIAN S, Camacho V, Sabate A, Stefaneli P, et al
    Audiovisual intervention alleviates anxiety of patients during PET/CT imaging.
    Nuklearmedizin. 2022;61:301-307.
    PubMed     Abstract available

    July 2022
  10. BEINDORFF N, Papadopoulos N, Hoffmann S, Mohan AM, et al
    Monitoring orthodontic tooth movement in rats after piezocision by bone scintigraphy.
    Nuklearmedizin. 2022 Jul 27. doi: 10.1055/a-1816-6825.
    PubMed     Abstract available

  11. HOLZGREVE A, Eilsberger F, Einspanner E, Kunz J, et al
    [The Youngsters of the German Society of Nuclear Medicine (Young DGN)].
    Nuklearmedizin. 2022 Jul 11. doi: 10.1055/a-1866-3000.

  12. HESCHELER DA, Stegger L, Schlack K, Bogemann M, et al
    Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement.
    Nuklearmedizin. 2022 Jul 11. doi: 10.1055/a-1809-4570.

    June 2022
  13. ZHANG R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, et al
    Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer.
    Nuklearmedizin. 2022 Jun 29. doi: 10.1055/a-1816-6950.
    PubMed     Abstract available

  14. TULIPAN AJ, Guzman AJ, Haslerud TM, Foldnes K, et al
    Enhancing PSMA-PET/CT with intravenous contrast: Improved tracer clearance in the prostate bed.
    Nuklearmedizin. 2022 Jun 14. doi: 10.1055/a-1821-8112.
    PubMed     Abstract available

  15. KURTH J, Potratz M, Heuschkel M, Krause BJ, et al
    GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals.
    Nuklearmedizin. 2022;61:247-261.
    PubMed     Abstract available

    April 2022
  16. SCHMIDT M, Bartenstein P, Bucerius J, Dietlein M, et al
    Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine.
    Nuklearmedizin. 2022 Apr 27. doi: 10.1055/a-1824-1280.

  17. FREUDENBERG R, Hesse L, Kotzerke J
    [Evaluation of radionuclide impurities in several radiopharmaceuticals].
    Nuklearmedizin. 2022 Apr 14. doi: 10.1055/a-1759-1815.
    PubMed     Abstract available

  18. WANKE C, Szemerski B, Geworski L
    [Incorporation Monitoring of Staff using I-131 and Lu-177 in a Nuclear Medicine Ward].
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1759-1940.
    PubMed     Abstract available

  19. RINSCHEID A, Janzen T, Alikhani B, Beer AJ, et al
    Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in Germany.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1759-3900.
    PubMed     Abstract available

  20. MULLER PJ, Dietlein M, Kobe C, Heidenreich A, et al
    Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1697-8111.
    PubMed     Abstract available

  21. EILSBERGER F, Girmond C, Boekhoff J, Librizzi D, et al
    [High clinical value of bone scintigraphy as a staging method for breast cancer].
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1780-8378.
    PubMed     Abstract available

  22. USLU H, Orhan Varoglu A, Tatoglu MT, Kilicaslan E, et al
    A Case of Chorea-Acanthocytosis with FDG PET/CT Imaging.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1780-8463.

  23. LENGANA T, Lawal I, Janse Van Rensburg C, Mokoala K, et al
    The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml.
    Nuklearmedizin. 2022;61:120-129.
    PubMed     Abstract available

  24. SCHMIDT M, Decarolis B, Franzius C, Hero B, et al

    Nuklearmedizin. 2022;61:96-110.

    March 2022
  25. SCHMIDT M, Bartenstein P, Bucerius J, Dietlein M, et al
    Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine.
    Nuklearmedizin. 2022 Mar 17. doi: 10.1055/a-1783-8154.
    PubMed     Abstract available

    February 2022
  26. BOSWIJK E, de Ligt M, Habets MJ, Mingels AMA, et al
    Resveratrol treatment does not reduce arterial inflammation in males at risk of type 2 diabetes: a randomized crossover trial.
    Nuklearmedizin. 2022;61:33-41.
    PubMed     Abstract available

  27. KOUKALOVA R, Vasina J, Stika J, Doubek M, et al
    Aggressive systemic mastocytosis with diffuse bone marrow 18F-FDG uptake.
    Nuklearmedizin. 2022;61:58-61.
    PubMed     Abstract available

    January 2022
  28. PARK SB, Lim CH, Chang WH, Hwang JH, et al
    Correction: Diagnostic Value of Bone SPECT/CT Using 99mTc-Methylene Diphosphonate in Patients with Unspecified Chest Wall Pain.
    Nuklearmedizin. 2022 Jan 21. doi: 10.1055/a-1728-8828.

  29. ROWE SP, Buck A, Bundschuh RA, Lapa C, et al
    [18F]DCFPyL PET/CT for Imaging of Prostate Cancer.
    Nuklearmedizin. 2022 Jan 14. doi: 10.1055/a-1659-0010.
    PubMed     Abstract available

    December 2021
  30. NAM HY, Seo S, Lee MJ, Kim K, et al
    No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects.
    Nuklearmedizin. 2021;60:434-437.
    PubMed     Abstract available

  31. BERLINER C, Boss K, Pape A, Kribben A, et al
    [Oldies (but Goldies): Peritoneal Scintigraphy in Chronic Peritoneal Dialysis Patients].
    Nuklearmedizin. 2021;60:450-453.

    November 2021
  32. RADZIKOWSKI KC, Rendl G, Beheshti M, Pirich C, et al
    18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.
    Nuklearmedizin. 2021 Nov 29. doi: 10.1055/a-1670-9315.

  33. PARK SB, Lim CH, Chang WH, Hwang JH, et al
    Diagnostic Value of Bone SPECT/CT Using 99mTc-Methylene Diphosphonate in Patients with Unspecified Chest Wall Pain.
    Nuklearmedizin. 2021 Nov 12. doi: 10.1055/a-1549-5910.
    PubMed     Abstract available

    October 2021
    Alpha emitting nuclides in nuclear medicine theranostics.
    Nuklearmedizin. 2021 Oct 8. doi: 10.1055/a-1650-9995.
    PubMed     Abstract available

  35. ROGASCH JMM, Penzkofer T
    AI in nuclear medicine - what, why and how?
    Nuklearmedizin. 2021;60:321-324.

    September 2021
  36. STOLZENBACH LF, Locherbach F, Wargenau K, Pose R, et al
    Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.
    Nuklearmedizin. 2021 Sep 3. doi: 10.1055/a-1626-6669.

  37. FARAG S, IJzerman NS, Houdijk MPM, Reyners AKL, et al
    Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intent.
    Nuklearmedizin. 2021 Sep 3. doi: 10.1055/a-1542-6211.
    PubMed     Abstract available

    August 2021
  38. STOLZENBACH LF, Locherbach F, Wargenau K, Pose R, et al
    Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.
    Nuklearmedizin. 2021 Aug 20. doi: 10.1055/a-1542-6064.
    PubMed     Abstract available

  39. POETZSCH S, Brenner W, Spreckelmeyer S
    Are radiopharmaceuticals self-sterilizing? Radiation effect of gallium-68 and lutetium-177 on bacillus pumilus and staphylococcus succinus.
    Nuklearmedizin. 2021 Aug 20. doi: 10.1055/a-1547-0628.
    PubMed     Abstract available

  40. YANG X, You Z, Chen Y, Dai T, et al
    Thymic squamous cell carcinoma mimicking lymphoma on 68Ga-FAPI PET/CT.
    Nuklearmedizin. 2021 Aug 17. doi: 10.1055/a-1561-2014.

  41. BECK MT, Rugel G, Reinfelder J, Kuwert T, et al
    Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw.
    Nuklearmedizin. 2021 Aug 11. doi: 10.1055/a-1525-7621.
    PubMed     Abstract available

  42. PATT M, Bengel F, Essler M, Krause BJ, et al
    [Fireside chat " section sign 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital].
    Nuklearmedizin. 2021;60:262-263.

  43. Nuklearmedizin. 2021;60:305.

  44. MIRZAEI S, Prior JO, Farsad M, Lipp RW, et al
    Ausbildung in Nuklearmedizin und Zukunftsperspektiven.
    Nuklearmedizin. 2021;60:264-265.

  45. SUI S, Hou Y
    Assessing Doxorubicin-Induced Cardiomyopathy by 99mTc-3PRGD2 Scintigraphy Targeting Integrin alphavbeta3 in a Rat Model.
    Nuklearmedizin. 2021;60:289-298.
    PubMed     Abstract available

    July 2021
  46. LAPA C, Nestle U, Albert NL, Baues C, et al
    Value of PET imaging for radiation therapy.
    Nuklearmedizin. 2021 Jul 14. doi: 10.1055/a-1525-7029.
    PubMed     Abstract available

  47. KREPPEL B, Gonzalez-Carmona MA, Feldmann G, Kuppers J, et al
    Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours.
    Nuklearmedizin. 2021 Jul 13. doi: 10.1055/a-1521-8604.
    PubMed     Abstract available

  48. SAHIN O, Kaya B, Aydin Z, Sen AE, et al
    Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parameters.
    Nuklearmedizin. 2021 Jul 9. doi: 10.1055/a-1525-7607.
    PubMed     Abstract available

    June 2021
  49. OBMANN VC, Grosse-Hokamp N, Alberts I, Fulton N, et al
    Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver.
    Nuklearmedizin. 2021 Jun 8. doi: 10.1055/a-1486-3671.
    PubMed     Abstract available

    Hope for new developments in the reimbursement of oncological PET/CT in Germany.
    Nuklearmedizin. 2021;60:205-208.

  51. FREUDENBERG LS, Klett R, Fischer M, Boddenberg-Patzold B, et al
    [RSO in clinical practice: Status in Germany 2020].
    Nuklearmedizin. 2021;60:224-232.
    PubMed     Abstract available

    April 2021
  52. BARENFANGER F, Block A, Schmelz D, Hamami-Arlinghaus M, et al
    Individual calculation of perfusion activity based on ventilation efficiency for V/P-SPECT.
    Nuklearmedizin. 2021 Apr 16. doi: 10.1055/a-1429-1832.
    PubMed     Abstract available

  53. TATOGLU MT, Uslu H, Ibisoglu E
    The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
    Nuklearmedizin. 2021 Apr 9. doi: 10.1055/a-1429-2237.

  54. FREUDENBERG LS, Essler M, Herrmann K
    [Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey].
    Nuklearmedizin. 2021 Apr 1. doi: 10.1055/a-1446-7641.
    PubMed     Abstract available

  55. Nuklearmedizin. 2021;60:76-77.

  56. PEKTOR S, Lawaczeck L, Tenzer S, Bausbacher N, et al
    Characterization of activation induced [18]F-FDG uptake in Dendritic Cells.
    Nuklearmedizin. 2021;60:90-98.
    PubMed     Abstract available

    February 2021

  57. Nuklearmedizin. 2021;60:59-63.

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.